Before you sell to, join or invest in LIPELLA PHARMACEUTICALS INC.
MentionFox check on LIPELLA PHARMACEUTICALS INC.: 2 red flags found in 3 sources (checked 4 November 2026). mentionfox.com/c/funding/lipella-pharmaceuticals-inc-form-d-25000001
Check LIPELLA PHARMACEUTICALS INC. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about LIPELLA PHARMACEUTICALS INC.?
Based on the records MentionFox holds for this company. No flag is not a clearance.
LIPELLA PHARMACEUTICALS INC. filed a Form D with the Securities and Exchange Commission on 2025-04-01.
LIPELLA PHARMACEUTICALS INC. filed a Form D notice of an exempt securities offering with the SEC on April 1, 2025. The filing reports $9K sold. Its industry group is Pharmaceuticals. It names Jonathan Kaufman (President, Chief Executive Officer, Secretary and Treasurer and Chairman of the Board of Directors), Michael Chancellor (Chief Medical Officer), Douglas Johnston (Chief Financial Officer) (SEC Form D, April 1, 2025).
Is this your company?
Sell to companies like LIPELLA PHARMACEUTICALS INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-04-01 · the record
Pitching, partnering or investing alongside them? See who really runs and owns LIPELLA PHARMACEUTICALS INC.
Free to see. No signup.
More on the people and the money behind LIPELLA PHARMACEUTICALS INC., from the filings we hold.
Pharmaceuticals raises by companies based in Pennsylvania, filed within 90 days of this one, largest first.
Get an email when LIPELLA PHARMACEUTICALS INC. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when LIPELLA PHARMACEUTICALS INC. raises, hires or launches. No email unless you switch it on.
Watch LIPELLA PHARMACEUTICALS INC. →Get the full cited report on LIPELLA PHARMACEUTICALS INC.
What the filing shows about LIPELLA PHARMACEUTICALS INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on LIPELLA PHARMACEUTICALS INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives LIPELLA PHARMACEUTICALS INC.'s address as 7800 Susquehanna St., Suite 505, Pittsburgh, PA 15208.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on LIPELLA PHARMACEUTICALS INC. See pricing
LIPELLA PHARMACEUTICALS INC. is a registered filer with the SEC (CIK 1347242) and has filed since 2023-09-12. 5 filings are on record, the latest on 2025-04-01.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
LIPELLA PHARMACEUTICALS INC.'s Form D of 2025-04-01 names Jonathan Kaufman, Michael Chancellor, Douglas Johnston and 5 more as its officers, directors or promoters.
Its new offerings report $4.73M sold across 4 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
On the filing as: Executive Officer, Director.
Jonathan Kaufman is named as President, Chief Executive Officer, Secretary and Treasurer and Chairman of the Board of Directors on the Form D that LIPELLA PHARMACEUTICALS INC. filed with the SEC on 1 April 2025, one of 8 people that filing names.
On the filing as: Executive Officer, Director.
Michael Chancellor is named as Chief Medical Officer on the Form D that LIPELLA PHARMACEUTICALS INC. filed with the SEC on 1 April 2025, one of 8 people that filing names.
On the filing as: Executive Officer.
Douglas Johnston is named as Chief Financial Officer on the Form D that LIPELLA PHARMACEUTICALS INC. filed with the SEC on 1 April 2025, one of 8 people that filing names.
Lori Birder is named as Director on the Form D that LIPELLA PHARMACEUTICALS INC. filed with the SEC on 1 April 2025, one of 8 people that filing names.
Ryan Pruchnic is named as Director on the Form D that LIPELLA PHARMACEUTICALS INC. filed with the SEC on 1 April 2025, one of 8 people that filing names.
Daniel Cohen is named as Director on the Form D that LIPELLA PHARMACEUTICALS INC. filed with the SEC on 1 April 2025, one of 8 people that filing names.
Byong Kim is named as Director on the Form D that LIPELLA PHARMACEUTICALS INC. filed with the SEC on 1 April 2025, one of 8 people that filing names.
Naoki Yoshimura is named as Director on the Form D that LIPELLA PHARMACEUTICALS INC. filed with the SEC on 1 April 2025, one of 8 people that filing names.
8 people named on the filing — 3 holding an executive role and 5 as directors only.
Named as of the 2025-04-01 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about LIPELLA PHARMACEUTICALS INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on LIPELLA PHARMACEUTICALS INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on LIPELLA PHARMACEUTICALS INC. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist LIPELLA PHARMACEUTICALS INC.You get an alert in MentionFox the next time this company shows up.
If you're behind LIPELLA PHARMACEUTICALS INC.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for LIPELLA PHARMACEUTICALS INC.. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in Pittsburgh
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/lipella-pharmaceuticals-inc-form-d-25000001